Medical Review Board

Pages on CCIWA that make clinical claims, describe medication mechanisms, or guide someone toward a treatment decision are reviewed by a credentialed clinician. The review board is the line we draw between data publishing, which we do well, and clinical interpretation, which requires medical training we do not have.

V1 launch disclosure. The V1 review slot below is held by a placeholder while the full V2 review board is being finalized. We will not pretend otherwise. Pages with clinical content that have not yet been reviewed by the V2 board are flagged at the bottom of those pages.

Reviewers

Jane Doe, MD (placeholder, V2 update pending)

Specialty: Addiction medicine, board certified (placeholder).
Role: Reviews clinical decision content including pages on methadone induction, buprenorphine prescribing, detox transitions, and overdose response.

We are publishing this placeholder name openly rather than fabricating a credential or hiding the gap. The V2 review board roster will replace this entry before any page makes a new clinical claim.

Review process

Page is drafted using federal data sources documented in the methodology.
Clinical content sections are flagged for review.
Reviewer reads the clinical sections, marks corrections, and signs off with a date.
The signed off date is published at the bottom of the reviewed page.
Material clinical claim changes trigger a fresh review cycle.

What review does not cover

Reviewers sign off on clinical accuracy. They do not confirm that any specific clinic is accepting new patients, that any specific phone number is connected today, or that any state coverage table is current beyond its source vintage. Operational data refresh cycles are documented in the methodology.

The named reviewer for any individual page is shown at the bottom of that page along with the most recent review date.